Evidence map›Paper›PMID 41238248›Full record

ArticleJACC. Case reports2025

Recognize, Monitor, Treat: A Comprehensive Approach to Improving Resistant Hypertension Care.

Lilit Vardanyan, Brenda Martinez-Puente, Milan Acosta, Kevin Khoa Trinh, Surabhi Atreja

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lilit VardanyanUniversity of California-Davis School of Medicine, Sacramento, California, USA. Electronic address: lvardanyan@health.ucdavis.edu.
Brenda Martinez-PuenteUniversity of California-Davis School of Medicine, Sacramento, California, USA.
Milan AcostaUniversity of California-Davis School of Medicine, Sacramento, California, USA.
Kevin Khoa TrinhUniversity of California-Davis School of Medicine, Sacramento, California, USA.
Surabhi AtrejaDepartment of Cardiovascular Medicine, University of California-Davis, Sacramento, California, USA. Electronic address: smatreja@health.ucdavis.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundResistant hypertension places individuals at significantly increased risk of adverse cardiovascular events. Current American College of Cardiology/American Heart Association guidelines highlight the importance of appropriate screening for secondary causes of hypertension and multimodal approaches to care. RATIONALE: Our findings show that only one-fourth of patients with systolic blood pressure (BP) above 160 mm Hg received any prior workup for secondary causes, displaying a major gap in care. SUMMARY: A population health-based registry was used to identify patients with uncontrolled resistant hypertension via electronic medical records, and a referral pathway with American College of Cardiology/American Heart Association-recommended evaluation was created for a multispecialty clinic. All identified patients were offered screening for secondary hypertension; 68% of whom were found with secondary causes. Mean systolic BP lowered below 140 mm Hg in 70% of patients, with over 30% reporting a drop of 20 mm Hg or more. TAKE-HOME MESSAGE: Multidisciplinary programs lead to early diagnosis, BP control, and overall improved quality of hypertension care.

Indexed as

blood pressuremultimodal approachesremote monitoringresistant hypertension

Identifiers

PMID41238248
PMCPMC12676155

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.